Seray Aslan Bayhan1, Hasan Ali Bayhan2, Emine Çölgeçen3, Canan Gürdal2. 1. Bozok University Faculty of Medicine, Ophthalmology Department, Yozgat, Turkey. Electronic address: seraybayhan@Hotmail.com. 2. Bozok University Faculty of Medicine, Ophthalmology Department, Yozgat, Turkey. 3. Bozok University Faculty of Medicine, Dermatology Department, Yozgat, Turkey.
Abstract
PURPOSE: To assess the ocular side effects during topical retinoid-antibiotic combination treatment in patients with facial acne vulgaris. METHODS: Forty-three patients applying topical isotretinoin+erythromycin combination (isotrexin gel, GlaxoSmithKline) once daily for the treatment of acne vulgaris were enrolled. Full ophthalmologic examination, Schirmer test (with topical anesthesia), fluorescein break-up time (BUT), corneal fluorescein staining and tear osmolarity measurement with the TearLab system (TearLab Corporation) were carried out before and at the end of the first month of the treatment. For evaluation of symptoms participants completed the ocular surface disease index (OSDI) questionnaire at each visit. RESULTS: The mean age of the patients was 23.16±3.03 (18-30) years. Mean tear osmolarity increased significantly from 282.09±8.95 mOsm/L at baseline to 300.39±16.65 mOsm/L after the treatment (p<0.001). BUT decreased from an average of 11.93±1.12s at baseline to 6.65±3.03s at the end of the first month (p<0.001). The OSDI score worsened significantly (5.41±3.65 vs 21.53±12.95, p<0.001) and punctate epitheliopathy was seen in 51% of eyes after the treatment. The average Schirmer values were 13.09±1.90 and 12.41±2.44mm/5min before and at the end of the first month of the treatment, respectively (p=0.117). CONCLUSIONS: The findings of this study indicate that topical retinoid-antibiotic combination treatment causes significant signs and symptoms of dry eye. Patients receiving topical treatment for acne should be evaluated regularly to ensure the timely detection and treatment of pathologic signs on the ocular surface.
PURPOSE: To assess the ocular side effects during topical retinoid-antibiotic combination treatment in patients with facial acne vulgaris. METHODS: Forty-three patients applying topical isotretinoin+erythromycin combination (isotrexin gel, GlaxoSmithKline) once daily for the treatment of acne vulgaris were enrolled. Full ophthalmologic examination, Schirmer test (with topical anesthesia), fluorescein break-up time (BUT), corneal fluorescein staining and tear osmolarity measurement with the TearLab system (TearLab Corporation) were carried out before and at the end of the first month of the treatment. For evaluation of symptoms participants completed the ocular surface disease index (OSDI) questionnaire at each visit. RESULTS: The mean age of the patients was 23.16±3.03 (18-30) years. Mean tear osmolarity increased significantly from 282.09±8.95 mOsm/L at baseline to 300.39±16.65 mOsm/L after the treatment (p<0.001). BUT decreased from an average of 11.93±1.12s at baseline to 6.65±3.03s at the end of the first month (p<0.001). The OSDI score worsened significantly (5.41±3.65 vs 21.53±12.95, p<0.001) and punctate epitheliopathy was seen in 51% of eyes after the treatment. The average Schirmer values were 13.09±1.90 and 12.41±2.44mm/5min before and at the end of the first month of the treatment, respectively (p=0.117). CONCLUSIONS: The findings of this study indicate that topical retinoid-antibiotic combination treatment causes significant signs and symptoms of dry eye. Patients receiving topical treatment for acne should be evaluated regularly to ensure the timely detection and treatment of pathologic signs on the ocular surface.
Authors: Kavita K Mishra; Jessica E Scholey; Inder K Daftari; Armin Afshar; Tony Tsai; Susanna Park; Jeanne M Quivey; Devron H Char Journal: Am J Ophthalmol Case Rep Date: 2020-06-22
Authors: María Carmen Sánchez-González; Concepción De-Hita-Cantalejo; Concepción Martínez-Lara; José-María Sánchez-González Journal: Front Med (Lausanne) Date: 2022-07-22